SE435289B - O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat - Google Patents

O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat

Info

Publication number
SE435289B
SE435289B SE7612053A SE7612053A SE435289B SE 435289 B SE435289 B SE 435289B SE 7612053 A SE7612053 A SE 7612053A SE 7612053 A SE7612053 A SE 7612053A SE 435289 B SE435289 B SE 435289B
Authority
SE
Sweden
Prior art keywords
cefem
beta
substituted
acylamino
amino
Prior art date
Application number
SE7612053A
Other languages
English (en)
Other versions
SE7612053L (sv
Inventor
R Scartazzini
H Bickel
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH978872A external-priority patent/CH587268A5/de
Priority claimed from CH1872272A external-priority patent/CH605987A5/de
Priority claimed from CH265573A external-priority patent/CH605988A5/de
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of SE7612053L publication Critical patent/SE7612053L/sv
Publication of SE435289B publication Critical patent/SE435289B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/02Preparation
    • C07D501/04Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/59Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3 with hetero atoms directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65613Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system (X = CH2, O, S, NH) optionally with an additional double bond and/or substituents, e.g. cephalosporins and analogs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE7612053A 1972-06-29 1976-10-29 O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat SE435289B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH978872A CH587268A5 (en) 1972-06-29 1972-06-29 Substd carboxylic acid derivs - broad spectrum antibiotics and inters
CH1219572 1972-08-17
CH1872272A CH605987A5 (en) 1972-12-22 1972-12-22 Substd carboxylic acid derivs
CH265573A CH605988A5 (en) 1973-02-23 1973-02-23 Substd 7-beta-amino ceph-3-em-3-ol 4-carboxylic acids

Publications (2)

Publication Number Publication Date
SE7612053L SE7612053L (sv) 1976-10-29
SE435289B true SE435289B (sv) 1984-09-17

Family

ID=27428472

Family Applications (5)

Application Number Title Priority Date Filing Date
SE7308235A SE417430B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE7308233A SE417429B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3ol-4-karboxylsyraforeningar
SE7308235A SE416812B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE7308234A SE417099B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE7612053A SE435289B (sv) 1972-06-29 1976-10-29 O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat

Family Applications Before (4)

Application Number Title Priority Date Filing Date
SE7308235A SE417430B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE7308233A SE417429B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3ol-4-karboxylsyraforeningar
SE7308235A SE416812B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar
SE7308234A SE417099B (sv) 1972-06-29 1973-06-12 Forfarande for framstellning av o-substituerade 7beta-amino-3-cefem-3-ol-4-karboxylsyraforeningar

Country Status (26)

Country Link
US (2) US4405778A (sv)
JP (3) JPS5933598B2 (sv)
AR (6) AR206201A1 (sv)
AT (5) ATA57675A (sv)
BE (1) BE801597A (sv)
BG (1) BG24954A3 (sv)
CA (1) CA1110230A (sv)
DD (3) DD106184A5 (sv)
DE (1) DE2331133C2 (sv)
DK (1) DK153324B (sv)
FI (3) FI60870C (sv)
FR (1) FR2190418B1 (sv)
GB (1) GB1435111A (sv)
HK (1) HK73778A (sv)
HU (3) HU169032B (sv)
IE (1) IE37767B1 (sv)
IL (1) IL42506A (sv)
LU (3) LU67887A1 (sv)
MY (1) MY7900008A (sv)
NL (3) NL7309139A (sv)
NO (3) NO145242C (sv)
PH (1) PH18567A (sv)
PL (1) PL91608B1 (sv)
RO (4) RO73345A (sv)
SE (5) SE417430B (sv)
YU (8) YU39910B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU36970B (en) * 1973-02-23 1984-08-31 Lilly Co Eli Process for obtaining 7-(amino)-acylamido-3-halocephalosporins
AU498131B2 (en) * 1974-02-26 1979-02-15 Ciba-Geigy Ag Production of cephems by cyclization
US4301278A (en) * 1974-02-26 1981-11-17 Ciba-Geigy Corporation Process for the manufacture of enol derivatives
US3928334A (en) * 1974-06-06 1975-12-23 Bristol Myers Co Process for the production of cefamandole
US4045435A (en) * 1974-10-09 1977-08-30 Eli Lilly And Company Preparation of cephalosporin ethers
US4147864A (en) * 1975-02-20 1979-04-03 Ciba-Geigy Corporation Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds
AT342197B (de) * 1975-02-20 1978-03-28 Ciba Geigy Ag Neues verfahren zur herstellung von 3-cephemverbindungen
CH622802A5 (sv) * 1975-08-20 1981-04-30 Ciba Geigy Ag
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
US4604386A (en) * 1984-07-09 1986-08-05 Eli Lilly And Company 3-(alkynylalkyloxy) cephalosporins
KR880001092B1 (ko) 1985-04-30 1988-06-23 일라이 릴리 앤드 캄파니 7-치환된 바이시클릭 피라졸리디논 및 그의 제조방법
JP2676763B2 (ja) * 1987-02-27 1997-11-17 萬有製薬株式会社 セファロスポリン誘導体
DE3851449T2 (de) * 1987-02-27 1995-03-16 Banyu Pharma Co Ltd Cephalosporinderivate, Verfahren zu ihrer Herstellung und antibakterielle Mittel.
JPS63255800A (ja) * 1987-04-14 1988-10-24 礒井 誠二郎 警報装置
AU618029B2 (en) * 1987-11-02 1991-12-12 Imperial Chemical Industries Plc Polypeptide compounds
GB8813356D0 (en) * 1988-06-06 1988-07-13 Ici Plc Polypeptide compounds
ES2093237T3 (es) 1991-07-03 1996-12-16 Ciba Geigy Ag Derivados de hidrazina farmacologicamente activos y procedimiento para su obtencion.
GB9115203D0 (en) * 1991-07-15 1991-08-28 Biochemie Gmbh Improvements in or relating to beta lactam production
US6979735B1 (en) * 1999-04-01 2005-12-27 Dsm N.V. Agglomerates by crystallization
US6627556B1 (en) 2002-04-24 2003-09-30 Lsi Logic Corporation Method of chemically altering a silicon surface and associated electrical devices
CN102268023B (zh) * 2011-08-15 2013-04-17 南京丰融化学技术有限公司 头孢类衍生物cxd的晶型
CN115160097B (zh) * 2022-07-22 2024-05-28 温州大学 一种硫代乙酸还原n-o键合成酰胺的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1308822A (en) * 1970-04-14 1973-03-07 Beecham Group Ltd 4-isopropylidene-3-oxocephams
GB1348985A (en) * 1970-06-16 1974-03-27 Merck & Co Inc Esters of cephalosporin compounds
IL37879A (en) * 1970-10-27 1974-12-31 Ciba Geigy Ag 3-unsubstituted cephalosporin derivatives,process for their manufacture and compositions containing them
US3704297A (en) * 1971-03-05 1972-11-28 American Home Prod 7 - (1,4 - cyclohexadienylacylamido)cephalosporanic acids and related compounds
US3741962A (en) * 1971-05-21 1973-06-26 Squibb & Sons Inc Alpha-thioureidocephalosporanic acid compounds
US3846417A (en) * 1972-06-23 1974-11-05 Squibb & Sons Inc 1,4-cyclohexadienyl imidazolidinyl cephalosporanic acids and derivatives thereof
US3917587A (en) * 1972-11-28 1975-11-04 Lilly Co Eli Cephalosporin ethers
US3917588A (en) * 1972-11-28 1975-11-04 Lilly Co Eli {60 -Aminoacyl cephalosporin ethers
US3907786A (en) * 1973-09-04 1975-09-23 Bristol Myers Co 7-{8 {60 -(2-aminomethyl-1,4-cyclohexadienyl)acetamido{9 -3-heterocyclic-thiomethyl-3-cephem-4-carboxylic acids and salts

Also Published As

Publication number Publication date
NL7309137A (sv) 1974-01-02
DK153324B (da) 1988-07-04
DD107470A5 (sv) 1974-08-05
IL42506A0 (en) 1973-08-29
SE7308234L (sv) 1973-12-31
JPS4949988A (sv) 1974-05-15
NO145240B (no) 1981-11-02
SE417429B (sv) 1981-03-16
RO64419A (fr) 1979-07-15
FI59601B (fi) 1981-05-29
FI59601C (fi) 1981-09-10
US4073902A (en) 1978-02-14
FI59602C (fi) 1981-09-10
AT356809B (de) 1980-05-27
YU284280A (en) 1983-01-21
ATA569573A (de) 1975-06-15
AT329762B (de) 1976-05-25
AR212028A1 (es) 1978-04-28
HK73778A (en) 1978-12-22
SE7308237L (sv) 1974-01-08
FR2190418A1 (sv) 1974-02-01
AR211871A1 (es) 1978-03-31
FR2190418B1 (sv) 1977-07-15
IE37767B1 (en) 1977-10-12
HU168017B (sv) 1976-02-28
AU5738673A (en) 1975-01-09
DE2331133A1 (de) 1974-01-17
DD106187A5 (sv) 1974-06-05
PL91608B1 (en) 1977-03-31
YU39909B (en) 1985-06-30
RO64226A (fr) 1979-05-15
YU179273A (en) 1982-06-30
RO63761A (fr) 1978-12-15
HU167726B (sv) 1975-12-25
NO145241C (no) 1982-02-10
SE417430B (sv) 1981-03-16
JPS4949987A (sv) 1974-05-15
DD106184A5 (sv) 1974-06-05
SE417099B (sv) 1981-02-23
AR212317A1 (es) 1978-06-30
AT329745B (de) 1976-05-25
ATA569673A (de) 1975-08-15
SE7308235L (sv) 1973-12-31
IE37767L (en) 1973-12-29
JPS5934716B2 (ja) 1984-08-24
YU39910B (en) 1985-06-30
NL7309139A (sv) 1974-01-02
SE7612053L (sv) 1976-10-29
YU179573A (en) 1982-06-30
YU39911B (en) 1985-06-30
LU67888A1 (sv) 1975-04-11
GB1435111A (en) 1976-05-12
AR212576A1 (es) 1978-08-15
NL7309136A (sv) 1974-01-02
MY7900008A (en) 1979-12-31
SE7308233L (sv) 1973-12-31
RO73345A (ro) 1982-09-09
LU67887A1 (sv) 1975-04-11
BG24954A3 (en) 1978-06-15
AR206201A1 (es) 1976-07-07
IL42506A (en) 1976-09-30
JPS5933599B2 (ja) 1984-08-16
YU223681A (en) 1983-06-30
HU169032B (sv) 1976-09-28
NO145242B (no) 1981-11-02
NO145240C (no) 1982-02-10
US4405778A (en) 1983-09-20
YU280780A (en) 1983-02-28
AT356810B (de) 1980-05-27
YU223881A (en) 1983-06-30
JPS5933598B2 (ja) 1984-08-16
YU179373A (en) 1982-06-30
FI60870C (fi) 1982-04-13
FI60870B (fi) 1981-12-31
BE801597A (fr) 1973-12-28
ATA57675A (de) 1975-08-15
JPS4949986A (sv) 1974-05-15
CA1110230A (en) 1981-10-06
YU223781A (en) 1983-06-30
NO145241B (no) 1981-11-02
NO145242C (no) 1982-02-10
PH18567A (en) 1985-08-12
ATA569473A (de) 1975-04-15
AR211870A1 (es) 1978-03-31
FI59602B (fi) 1981-05-29
SE416812B (sv) 1981-02-09
DE2331133C2 (de) 1984-04-12
LU67891A1 (sv) 1975-04-11

Similar Documents

Publication Publication Date Title
SE435289B (sv) O-substituerade 7 beta-amino-3-cefem-3-ol-4-karbonsyraderivat till anvendning som mellanprodukt for framstellning av o-substituerade 7 beta-acylamino-3-cefem-3-ol-4-karbonsyraderivat
SE400280B (sv) 2-halogen-4-substituerade-6,7,8-trialkoxikinazoliner till anvendning som mellanprodukt for framstellning av terapeutiskt aktiva 2-substituerade-4-amino-6,7,8-trialkoxikinazoliner
SE401978B (sv) Harkosmetiska beredningar innehallande derivat av 1-hydroxi-2-pyridoner som antimjellmedel
AR195097A1 (es) Procedimiento para la preparacion de nuevos derivados de la pirrolo(3,4-b)pirazina
SE444809B (sv) Alfa-skyddade oxiimino-beta-oxo-gamma-halogensmorsyraderivat till anvendning som mellanprodukt for framstellning av farmaceutiskt anvendbara cefemforeningar
SE390819B (sv) Analogiforfarande for framstellning av piperazinyl-propyl-1,2,4-triazolinderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE403106B (sv) Forfarande vid framstellning av 14-hydroximorfinanderivat
SE399879B (sv) Kemiska mellanprodukter till anvendning for framstellning av terapeutiskt verdefulla 1,2,3,4-tetrahydro-4-fenyl-isokinolinderivat
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE385698B (sv) Forfarande for framstellning av kinolinettiksyraderivat
SE396592B (sv) Foreningen difluorometyl-2,2,3,3-tetrafluoropropyleter till anvendning som mellanprodukt vid framstellning av difluormetyl-1,2,2,3,3-pentafluoropropyleter
NO143531C (no) Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater.
SE399708B (sv) Forfarande for framstellning av tioxanton-2-karboxylsyraderivat
SE402009B (sv) Forfarande for framstellning av 9-desoxi-prosta-5,9,(10),13-triensyraderivat
IT1021055B (it) Procedimento per la preparazione di 2 2 6 6 tetrametil 4 ossopiperidina
NO142815C (no) Acetidinderivater som anvendes som utgangsmateriale for fremstilling av cefalosporansyrederivater
SE400768B (sv) Forfarande for framstellning av 2-fenyl-6-sulfamoyl-7-klor-1,2,3,4-tetrahydro-4-kinazolinon
SE398235B (sv) 2- och 3-substituerade-4-tia-2,6-diazabicyklo/3,2,0/heptan-7-on-foreningar till anvendning som mellanprodukt for framstellning av 7-n-acylamino-cefalosporansyraforeningar
NO142307C (no) Fremgangsmaate ved fremstilling av pregnansyrederivater
SE388611B (sv) Analogiforfarande for framstellning av 1,4-bensodiazeponderivat
SE400086B (sv) Forfarande for framstellning av acylerade n(6)- aralkyl-adenosin-derivat
NO140736C (no) Fremgangsmaate til fremstilling av poly-alfa-oksyakrylsyre
SE404367B (sv) Forfarande for framstellning av derivat av homofolsyra
SE403613B (sv) Analogiforfarande for framstellning av vissa angivna 3,4,5-trimetoxiacetofenonoximkarbamatderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7612053-4

Effective date: 19900522

Format of ref document f/p: F